http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-19980701640-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4045 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P39-02 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4045 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40 |
| filingDate | 1996-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1998-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-19980701640-A |
| titleOfInvention | Use of Melatonin for the Treatment of Pharmaceutical Addiction Patients |
| abstract | To treat melatonin with multiple drug addictions, or patients with benzodiazepine dependency, resistance or addiction, or patients diagnosed clinically as having conditions alleviated by the administration of benzodiazepine drugs, the benzodiazepine drug dependency, resistance or addiction It is used in the manufacture of drugs for the treatment of symptoms while preventing symptoms occurring in the patient. The present invention also relates to pharmaceutical preparations for the above purposes comprising benzodiazepine agents and melatonin as active ingredients and containing at least one of diluents, carriers or adjuvants. |
| priorityDate | 1995-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 43.